Article ID Journal Published Year Pages File Type
5697906 Clinical Oncology 2016 7 Pages PDF
Abstract
Chemo-IMRT for LA-NPC is feasible with good survival outcomes. At 1 year, 31% experience ≥grade 2 subjective xerostomia.
Related Topics
Health Sciences Medicine and Dentistry Oncology
Authors
, , , , , , , , , , ,